MACRAE SANDY (PRESIDENT, CEO AND DIRECTOR) reported 1 transaction at SANGAMO THERAPEUTICS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 5/28/2025ACC: 0001415889-25-014692
DirectorOfficer· PRESIDENT, CEO AND DIRECTOR
Since Feb 2026
-7.49K
Net shares
Net seller
$3.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
7.49K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.49K
Price / share
$0.47
Trade value
$3.54K
% of position
0.3%
5/24/2025
2.33M→2.32M
Total
Net shares
−7.49K
Net value
-$3.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/24/2025 | F · Tax Withholding | −7.49K | $0.47 | $3.54K | 0.3% | 2.33M | 2.32M |
| Total | −7.49K | -$3.54K | ||||||
Derivative Transactions0
No derivative transactions reported